Report Detail

Pharma & Healthcare Global Aripiprazole Drug Market Growth 2019-2024

  • RnM2772474
  • |
  • 15 January, 2019
  • |
  • Global
  • |
  • 134 Pages
  • |
  • LPI(LP Information)
  • |
  • Pharma & Healthcare

Aripiprazole, sold under the brand name Abilify among others, is an atypical antipsychotic. It is primarily used in the treatment of schizophrenia and bipolar disorder. Other uses include as an add-on treatment in major depressive disorder, tic disorders, and irritability associated with autism.

According to this study, over the next five years the Aripiprazole Drug market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2024, from US$ xx million in 2017. In particular, this report presents the global market share (sales and revenue) of key companies in Aripiprazole Drug business, shared in Chapter 3.

This report presents a comprehensive overview, market shares, and growth opportunities of Aripiprazole Drug market by product type, application, key manufacturers and key regions and countries.

This study considers the Aripiprazole Drug value and volume generated from the sales of the following segments:

Segmentation by product type: breakdown data from 2013 to 2018, in Section 2.3; and forecast to 2024 in section 11.7.
Tablets
Orally Disintegrating Tablets
Oral Solution
Injection
Segmentation by application: breakdown data from 2013 to 2018, in Section 2.4; and forecast to 2024 in section 11.8.
Adult Patients
Pediatric Patients

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Otsuka Pharmaceutical
Teva
APOTEX
Barr Laboratories
Sun Pharmaceutical
Alembic Pharmaceuticals
Orchid Pharma
Amneal
Aurobindo Pharma
Lannett

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives
To study and analyze the global Aripiprazole Drug consumption (value & volume) by key regions/countries, product type and application, history data from 2013 to 2017, and forecast to 2024.
To understand the structure of Aripiprazole Drug market by identifying its various subsegments.
Focuses on the key global Aripiprazole Drug manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Aripiprazole Drug with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Aripiprazole Drug submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.


Table of Contents

    2018-2023 Global Aripiprazole Drug Consumption Market Report

      1 Scope of the Report

      • 1.1 Market Introduction
      • 1.2 Research Objectives
      • 1.3 Years Considered
      • 1.4 Market Research Methodology
      • 1.5 Economic Indicators
      • 1.6 Currency Considered

      2 Executive Summary

      • 2.1 World Market Overview
        • 2.1.1 Global Aripiprazole Drug Consumption 2013-2023
        • 2.1.2 Aripiprazole Drug Consumption CAGR by Region
      • 2.2 Aripiprazole Drug Segment by Type
        • 2.2.1 Tablets
        • 2.2.2 Orally Disintegrating Tablets
        • 2.2.3 Oral Solution
        • 2.2.4 Injection
      • 2.3 Aripiprazole Drug Consumption by Type
        • 2.3.1 Global Aripiprazole Drug Consumption Market Share by Type (2013-2018)
        • 2.3.2 Global Aripiprazole Drug Revenue and Market Share by Type (2013-2018)
        • 2.3.3 Global Aripiprazole Drug Sale Price by Type (2013-2018)
      • 2.4 Aripiprazole Drug Segment by Application
        • 2.4.1 Adult Patients
        • 2.4.2 Pediatric Patients
      • 2.5 Aripiprazole Drug Consumption by Application
        • 2.5.1 Global Aripiprazole Drug Consumption Market Share by Application (2013-2018)
        • 2.5.2 Global Aripiprazole Drug Value and Market Share by Application (2013-2018)
        • 2.5.3 Global Aripiprazole Drug Sale Price by Application (2013-2018)

      3 Global Aripiprazole Drug by Players

      • 3.1 Global Aripiprazole Drug Sales Market Share by Players
        • 3.1.1 Global Aripiprazole Drug Sales by Players (2016-2018)
        • 3.1.2 Global Aripiprazole Drug Sales Market Share by Players (2016-2018)
      • 3.2 Global Aripiprazole Drug Revenue Market Share by Players
        • 3.2.1 Global Aripiprazole Drug Revenue by Players (2016-2018)
        • 3.2.2 Global Aripiprazole Drug Revenue Market Share by Players (2016-2018)
      • 3.3 Global Aripiprazole Drug Sale Price by Players
      • 3.4 Global Aripiprazole Drug Manufacturing Base Distribution, Sales Area, Product Types by Players
        • 3.4.1 Global Aripiprazole Drug Manufacturing Base Distribution and Sales Area by Players
        • 3.4.2 Players Aripiprazole Drug Products Offered
      • 3.5 Market Concentration Rate Analysis
        • 3.5.1 Competition Landscape Analysis
        • 3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2016-2018)
      • 3.6 New Products and Potential Entrants
      • 3.7 Mergers & Acquisitions, Expansion

      4 Aripiprazole Drug by Regions

      • 4.1 Aripiprazole Drug by Regions
        • 4.1.1 Global Aripiprazole Drug Consumption by Regions
        • 4.1.2 Global Aripiprazole Drug Value by Regions
      • 4.2 Americas Aripiprazole Drug Consumption Growth
      • 4.3 APAC Aripiprazole Drug Consumption Growth
      • 4.4 Europe Aripiprazole Drug Consumption Growth
      • 4.5 Middle East & Africa Aripiprazole Drug Consumption Growth

      5 Americas

      • 5.1 Americas Aripiprazole Drug Consumption by Countries
        • 5.1.1 Americas Aripiprazole Drug Consumption by Countries (2013-2018)
        • 5.1.2 Americas Aripiprazole Drug Value by Countries (2013-2018)
      • 5.2 Americas Aripiprazole Drug Consumption by Type
      • 5.3 Americas Aripiprazole Drug Consumption by Application
      • 5.4 United States
      • 5.5 Canada
      • 5.6 Mexico
      • 5.7 Key Economic Indicators of Few Americas Countries

      6 APAC

      • 6.1 APAC Aripiprazole Drug Consumption by Countries
        • 6.1.1 APAC Aripiprazole Drug Consumption by Countries (2013-2018)
        • 6.1.2 APAC Aripiprazole Drug Value by Countries (2013-2018)
      • 6.2 APAC Aripiprazole Drug Consumption by Type
      • 6.3 APAC Aripiprazole Drug Consumption by Application
      • 6.4 China
      • 6.5 Japan
      • 6.6 Korea
      • 6.7 Southeast Asia
      • 6.8 India
      • 6.9 Australia
      • 6.10 Key Economic Indicators of Few APAC Countries

      7 Europe

      • 7.1 Europe Aripiprazole Drug by Countries
        • 7.1.1 Europe Aripiprazole Drug Consumption by Countries (2013-2018)
        • 7.1.2 Europe Aripiprazole Drug Value by Countries (2013-2018)
      • 7.2 Europe Aripiprazole Drug Consumption by Type
      • 7.3 Europe Aripiprazole Drug Consumption by Application
      • 7.4 Germany
      • 7.5 France
      • 7.6 UK
      • 7.7 Italy
      • 7.8 Russia
      • 7.9 Spain
      • 7.10 Key Economic Indicators of Few Europe Countries

      8 Middle East & Africa

      • 8.1 Middle East & Africa Aripiprazole Drug by Countries
        • 8.1.1 Middle East & Africa Aripiprazole Drug Consumption by Countries (2013-2018)
        • 8.1.2 Middle East & Africa Aripiprazole Drug Value by Countries (2013-2018)
      • 8.2 Middle East & Africa Aripiprazole Drug Consumption by Type
      • 8.3 Middle East & Africa Aripiprazole Drug Consumption by Application
      • 8.4 Egypt
      • 8.5 South Africa
      • 8.6 Israel
      • 8.7 Turkey
      • 8.8 GCC Countries

      9 Market Drivers, Challenges and Trends

      • 9.1 Market Drivers and Impact
        • 9.1.1 Growing Demand from Key Regions
        • 9.1.2 Growing Demand from Key Applications and Potential Industries
      • 9.2 Market Challenges and Impact
      • 9.3 Market Trends

      10 Marketing, Distributors and Customer

      • 10.1 Sales Channel
        • 10.1.1 Direct Marketing
        • 10.1.2 Indirect Marketing
      • 10.2 Aripiprazole Drug Distributors
      • 10.3 Aripiprazole Drug Customer

      11 Global Aripiprazole Drug Market Forecast

      • 11.1 Global Aripiprazole Drug Consumption Forecast (2018-2023)
      • 11.2 Global Aripiprazole Drug Forecast by Regions
        • 11.2.1 Global Aripiprazole Drug Forecast by Regions (2018-2023)
        • 11.2.2 Global Aripiprazole Drug Value Forecast by Regions (2018-2023)
        • 11.2.3 Americas Consumption Forecast
        • 11.2.4 APAC Consumption Forecast
        • 11.2.5 Europe Consumption Forecast
        • 11.2.6 Middle East & Africa Consumption Forecast
      • 11.3 Americas Forecast by Countries
        • 11.3.1 United States Market Forecast
        • 11.3.2 Canada Market Forecast
        • 11.3.3 Mexico Market Forecast
        • 11.3.4 Brazil Market Forecast
      • 11.4 APAC Forecast by Countries
        • 11.4.1 China Market Forecast
        • 11.4.2 Japan Market Forecast
        • 11.4.3 Korea Market Forecast
        • 11.4.4 Southeast Asia Market Forecast
        • 11.4.5 India Market Forecast
        • 11.4.6 Australia Market Forecast
      • 11.5 Europe Forecast by Countries
        • 11.5.1 Germany Market Forecast
        • 11.5.2 France Market Forecast
        • 11.5.3 UK Market Forecast
        • 11.5.4 Italy Market Forecast
        • 11.5.5 Russia Market Forecast
        • 11.5.6 Spain Market Forecast
      • 11.6 Middle East & Africa Forecast by Countries
        • 11.6.1 Egypt Market Forecast
        • 11.6.2 South Africa Market Forecast
        • 11.6.3 Israel Market Forecast
        • 11.6.4 Turkey Market Forecast
        • 11.6.5 GCC Countries Market Forecast
      • 11.7 Global Aripiprazole Drug Forecast by Type
      • 11.8 Global Aripiprazole Drug Forecast by Application

      12 Key Players Analysis

      • 12.1 Otsuka Pharmaceutical
        • 12.1.1 Company Details
        • 12.1.2 Aripiprazole Drug Product Offered
        • 12.1.3 Otsuka Pharmaceutical Aripiprazole Drug Sales, Revenue, Price and Gross Margin (2016-2018)
        • 12.1.4 Main Business Overview
        • 12.1.5 Otsuka Pharmaceutical News
      • 12.2 Teva
        • 12.2.1 Company Details
        • 12.2.2 Aripiprazole Drug Product Offered
        • 12.2.3 Teva Aripiprazole Drug Sales, Revenue, Price and Gross Margin (2016-2018)
        • 12.2.4 Main Business Overview
        • 12.2.5 Teva News
      • 12.3 APOTEX
        • 12.3.1 Company Details
        • 12.3.2 Aripiprazole Drug Product Offered
        • 12.3.3 APOTEX Aripiprazole Drug Sales, Revenue, Price and Gross Margin (2016-2018)
        • 12.3.4 Main Business Overview
        • 12.3.5 APOTEX News
      • 12.4 Barr Laboratories
        • 12.4.1 Company Details
        • 12.4.2 Aripiprazole Drug Product Offered
        • 12.4.3 Barr Laboratories Aripiprazole Drug Sales, Revenue, Price and Gross Margin (2016-2018)
        • 12.4.4 Main Business Overview
        • 12.4.5 Barr Laboratories News
      • 12.5 Sun Pharmaceutical
        • 12.5.1 Company Details
        • 12.5.2 Aripiprazole Drug Product Offered
        • 12.5.3 Sun Pharmaceutical Aripiprazole Drug Sales, Revenue, Price and Gross Margin (2016-2018)
        • 12.5.4 Main Business Overview
        • 12.5.5 Sun Pharmaceutical News
      • 12.6 Alembic Pharmaceuticals
        • 12.6.1 Company Details
        • 12.6.2 Aripiprazole Drug Product Offered
        • 12.6.3 Alembic Pharmaceuticals Aripiprazole Drug Sales, Revenue, Price and Gross Margin (2016-2018)
        • 12.6.4 Main Business Overview
        • 12.6.5 Alembic Pharmaceuticals News
      • 12.7 Orchid Pharma
        • 12.7.1 Company Details
        • 12.7.2 Aripiprazole Drug Product Offered
        • 12.7.3 Orchid Pharma Aripiprazole Drug Sales, Revenue, Price and Gross Margin (2016-2018)
        • 12.7.4 Main Business Overview
        • 12.7.5 Orchid Pharma News
      • 12.8 Amneal
        • 12.8.1 Company Details
        • 12.8.2 Aripiprazole Drug Product Offered
        • 12.8.3 Amneal Aripiprazole Drug Sales, Revenue, Price and Gross Margin (2016-2018)
        • 12.8.4 Main Business Overview
        • 12.8.5 Amneal News
      • 12.9 Aurobindo Pharma
        • 12.9.1 Company Details
        • 12.9.2 Aripiprazole Drug Product Offered
        • 12.9.3 Aurobindo Pharma Aripiprazole Drug Sales, Revenue, Price and Gross Margin (2016-2018)
        • 12.9.4 Main Business Overview
        • 12.9.5 Aurobindo Pharma News
      • 12.10 Lannett
        • 12.10.1 Company Details
        • 12.10.2 Aripiprazole Drug Product Offered
        • 12.10.3 Lannett Aripiprazole Drug Sales, Revenue, Price and Gross Margin (2016-2018)
        • 12.10.4 Main Business Overview
        • 12.10.5 Lannett News

      13 Research Findings and Conclusion

      Summary:
      Get latest Market Research Reports on Aripiprazole Drug . Industry analysis & Market Report on Aripiprazole Drug is a syndicated market report, published as Global Aripiprazole Drug Market Growth 2019-2024. It is complete Research Study and Industry Analysis of Aripiprazole Drug market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

      Last updated on

      REPORT YOU MIGHT BE INTERESTED

      Purchase this Report

      $3,660.00
      $5,490.00
      $7,320.00
      2,909.70
      4,364.55
      5,819.40
      3,385.50
      5,078.25
      6,771.00
      572,497.20
      858,745.80
      1,144,994.40
      305,719.80
      458,579.70
      611,439.60
      Credit card Logo

      Related Reports


      Reason to Buy

      Request for Sample of this report